a simple and highly sensitive radioimmunoassay ( ria ) procedure has been developed for the determination of the new antihypertensive drug 2- [ ( 2-chloro-4-methyl-3-thienyl ) amino ] -2-imidazoline ( tiamenidine ) in serum , plasma and urine .
C0229671
serum
C0032105
plasma